If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback